Hello, Welcome to LEAPChem.com

ADC Linkers


11095_2015_1657_Fig6_HTML.pngADC linkers are one of the three main components of the antibody drug conjugates (ADC) that connect an antibody with a potent drug (payload) through a chemical bond.

 

ADC linkers play key roles in determining the overall success of the Antibody Drug Conjugates. One of the main challenges in developing a safe and effective ADC drug is the assembly of a desirable chemical linker between cytotoxic payload and mAb. A well-designed ADC linker can help the antibody to selectively deliver and accurately release the cytotoxic drug at tumor sites. It also plays critical roles in an ADCs' stability during preparation, storage, and systemic circulation. A stable ADC drug ensures that less cytotoxic payloads fall off before reaching tumor cells, increasing safety, and limiting dose.

 

There are two main categories of ADC linkers in current ADC drugs, cleavable linkers and non-cleavable linkers.

1.         Cleavable linker: The linker may be cleavable. Here, a chemical bond (or multiple chemical bonds) between the payload and the antibody attachment site (usually an amino acid) will be cleaved intracellularly. The cleavable linker can be degraded under different pH values or the action of intracellular enzymes to achieve the separation of chemical drugs from antibodies. Adcetris uses this kind of linker. Since the chemical may escape from the target cell after the drug is released, the drug can also kill the adjacent tissue of the target cell.

2.         Noncleavable linker: The noncleavable linker maintains the coupling integrity of the antibody and the chemical drug throughout the entire drug action process. The final active metabolite, released by ADC in the lysosome after complete hydrolysis by the protease, contains the payloads and all the constituent elements of the linker still connected to the amino acid residues of the antibody, which is usually lysine or cysteine residue. Kadcyla uses this kind of non-cleavable linker, so the drug will eventually degrade into a mixture of amino acids, antibodies, chemicals and other components after entering the target cells.

 

LEAPChem offers a wide range of different cleavable linkers, non-cleavable linkers, linker payload, and other linkages to empower our customer’s advanced research worldwide. These compounds feature great aqueous solubility, and a broad selection of functional groups to choose from. 


CAS No.Product NameSmiles
Non-Cleavable Linker
71875-81-5SMCCO=C(ON1C(=O)CCC1=O)[C@@H]2CC[C@@H](CN3C(=O)C=CC3=O)CC2
64987-85-5SMCCO=C(ON1C(=O)CCC1=O)C2CCC(CN3C(=O)C=CC3=O)CC2
103750-03-45-Maleimidovalericacid-NHSO=C(CCCCN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
80307-12-6GMBSO=C(CCCN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
55750-63-5EMCSO=C(CCCCCN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
55750-61-3N-SMPO=C(CN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
756525-99-2Mal-DPEG4-NHSO=C(CCN1C(=O)C=CC1=O)NCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
1334177-86-4Mal-amido-PEG8-acidOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCN1C(=O)C=CC1=O
1599472-25-9Mal-PEG6-NHS esterO=C(CCOCCOCCOCCOCCOCCOCCN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
1537892-36-6Mal-PEG3-NHS esterO=C(CCOCCOCCOCCN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
1807534-78-6Mal-PEG3-PFP esterFc1c(F)c(F)c(OC(=O)CCOCCOCCOCCN2C(=O)C=CC2=O)c(F)c1F
1008402-79-6Bis(NHS)PEG9O=C(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O)ON2C(=O)CCC2=O
756526-03-1Bis(NHS)PEG5O=C(CCOCCOCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O)ON2C(=O)CCC2=O
1314378-11-4NHS-PEG3-NHSO=C(CCOCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O)ON2C(=O)CCC2=O
1314378-16-9Bis-PEG3-NHS EsterO=C(CCOCCOCCOCCC(=O)ON1C(=O)CCC1=O)ON2C(=O)CCC2=O
65869-63-8Bis-PEG2-NHS EsterO=C(CCOCCOCCC(=O)ON1C(=O)CCC1=O)ON2C(=O)CCC2=O
65869-64-9Bis-PEG1-NHS esterO=C(CCOCCC(=O)ON1C(=O)CCC1=O)ON2C(=O)CCC2=O
1312309-64-0Azido-PEG2-NHS ester[N-]=[N+]=NCCOCCOCCC(=O)ON1C(=O)CCC1=O
478801-48-85-azidopentanoic acid N-hydroxysuccinimide ester[N-]=[N+]=NCCCCC(=O)ON1C(=O)CCC1=O
943858-70-6succimimidyl-4-azidobutyrate[N-]=[N+]=NCCCC(=O)ON1C(=O)CCC1=O
824426-32-6NHS-Ac-N3[N-]=[N+]=NCC(=O)ON1C(=O)CCC1=O
1421932-52-6endo-BCN-PEG4-PFP esterFc1c(F)c(F)c(OC(=O)CCOCCOCCOCCOCCNC(=O)OCC2C3CCC#CCCC23)c(F)c1F
1421932-53-7endo-BCN-PEG2-PFP esterFc1c(F)c(F)c(OC(=O)CCOCCOCCNC(=O)OCC2C3CCC#CCCC23)c(F)c1F
1425803-45-72,5-dioxopyrrolidin-1-yl 2-(cyclooct-2-ynyloxy)acetateO=C(COC1CCCCCC#C1)ON2C(=O)CCC2=O
1428629-70-2Propargyl-PEG4-NHS esterO=C(CCOCCOCCOCCOCC#C)ON1C(=O)CCC1=O
906564-59-85-hexynoic NHS esterO=C(CCCC#C)ON1C(=O)CCC1=O
132178-37-14-pentynoic acid succinimidyl esterO=C(CCC#C)ON1C(=O)CCC1=O
1347750-81-5MAL-Di-EG-OPFPFc1c(F)c(F)c(OC(=O)CCOCCOCCNC(=O)CCN2C(=O)C=CC2=O)c(F)c1F
1263044-56-9Mal-PEG10-NHSO=C(CCCCCN1C(=O)C=CC1=O)NCCOCCOCCC(=O)ON2C(=O)CCC2=O
1137109-22-8Maleimide-NH-PEG10-CH2CH2COONHS EsterO=C(CCN1C(=O)C=CC1=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
756525-93-6Mal-PEG8-NHSO=C(CCN1C(=O)C=CC1=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
1137109-21-7Mal-PEG6-NHSO=C(CCN1C(=O)C=CC1=O)NCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
1315355-92-0Mal-PEG5-NHSO=C(CCN1C(=O)C=CC1=O)NCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
1347750-84-8Maleimide-NH-PEG4-CH2CH2COOPFP EsterFc1c(F)c(F)c(OC(=O)CCOCCOCCOCCOCCNC(=O)CCN2C(=O)C=CC2=O)c(F)c1F
955094-26-5Mal-PEG2-NHSO=C(CCN1C(=O)C=CC1=O)NCCOCCOCCC(=O)ON2C(=O)CCC2=O
1260092-50-9Mal-PEG-NHSO=C(CCN1C(=O)C=CC1=O)NCCOCCC(=O)ON2C(=O)CCC2=O
1415800-42-8Mal-PEG4-PFPFc1c(F)c(F)c(OC(=O)CCOCCOCCOCCOCCN2C(=O)C=CC2=O)c(F)c1F
1325208-25-0Mal-PEG4-NHSO=C(CCOCCOCCOCCOCCN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
1807512-47-5Mal-PEG2-PFPFc1c(F)c(F)c(OC(=O)CCOCCOCCN2C(=O)C=CC2=O)c(F)c1F
1433997-01-3Mal-PEG2-NHSO=C(CCOCCOCCN1C(=O)C=CC1=O)ON2C(=O)CCC2=O
Cleavable Linker (Chemically-Cleavable)
Acid-Cleavable
65623-82-74-(4-Acetyl-phenoxy)-butyric acidCC(=O)c1ccc(OCCCC(=O)O)cc1
60444-78-22,5-dioxopyrrolidin-1-yl 4-formylbenzoateO=Cc1ccc(cc1)C(=O)ON2C(=O)CCC2=O
1309460-27-2Ald-Ph-PEG4-acidOC(=O)CCOCCOCCOCCOCCNC(=O)c1ccc(C=O)cc1
1007215-91-9Ald-Ph-PEG3-acidOC(=O)COCCOCCOCCNC(=O)c1ccc(C=O)cc1
1061569-06-9Ald-Ph-PEG2-acidOCCOCCNC(=O)c1ccc(C=O)cc1
1007215-94-2tert-butyl   1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oateCC(C)(C)OC(=O)COCCOCCOCCNC(=O)c1ccc(C=O)cc1
1245813-70-0tert-butyl   1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamateCC(C)(C)OC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(C=O)cc1
1337889-01-6N-(35-amino-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontyl)-4-formylbenzamideNCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(C=O)cc1
1324007-10-4Ald-PEG4-PFPFc1c(F)c(F)c(OC(=O)CCOCCOCCOCCOCCNC(=O)c2ccc(C=O)cc2)c(F)c1F
1353011-74-1Ald-PEG4-NHS esterO=Cc1ccc(cc1)C(=O)NCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
1807521-07-8Ald-Ph-PEG2-NHSO=Cc1ccc(cc1)C(=O)NCCOCCOCCC(=O)ON2C(=O)CCC2=O
Reductive-Cleavable
68181-17-9SPDPO=C(CCSSc1ccccn1)ON2C(=O)CCC2=O
890409-85-52,5-dioxopyrrolidin-1-yl   4-methyl-4-(pyridin-2-yldisulfanyl)pentanoateCC(C)(CCC(=O)ON1C(=O)CCC1=O)SSc2ccccn2
874302-76-84-nitrophenyl 2-(pyridin-2-yldisulfanyl)ethyl carbonate[O-][N+](=O)c1ccc(OC(=O)OCCSSc2ccccn2)cc1
1252257-56-9SPDP-PEG8-NHSO=C(CCSSc1ccccn1)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
1305053-43-3Pyridin-2-yldisulfanyl-PEG4-NHSO=C(CCOCCOCCOCCOCCSSc1ccccn1)ON2C(=O)CCC2=O
1824718-79-7N-succinimidyl-6-(2-pyridyldithio)capronateO=C(CCCCCSSc1ccccn1)ON2C(=O)CCC2=O
317331-86-5N-succinimidyl-5-(2-pyridyldithio)valerateO=C(CCCCSSc1ccccn1)ON2C(=O)CCC2=O
663598-98-92,5-dioxopyrrolidin-1-yl   4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoateCC(C)(CCC(=O)ON1C(=O)CCC1=O)SSc2ccc(cn2)[N+](=O)[O-]
1193111-39-51-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic   acidOS(=O)(=O)C(CCSSc1ccccn1)C(=O)ON2C(=O)CCC2=O
663598-85-4N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate[O-][N+](=O)c1ccc(SSCCCC(=O)ON2C(=O)CCC2=O)nc1
107348-47-02,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoateCC(CC(=O)ON1C(=O)CCC1=O)SSc2ccccn2
160580-70-1perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoateFc1c(F)c(F)c(OC(=O)CCSSc2ccccn2)c(F)c1F
121115-30-82,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic   acidOS(=O)(=O)C1CC(=O)N(OC(=O)CCSSc2ccccn2)C1=O
1610769-13-54-((S)-2-((S)-2-amino-3-methylbutanamido)-5-ureidopentanamido)benzyl   2-(pyridin-2-yldisulfanyl)ethylcarbamateCC(C)[C@H](N)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc1ccc(COC(=O)NCCSSc2ccccn2)cc1
Cleavable Linker (Enzyme-Cleavable)
Cathepsin Cleavable
159857-81-5Mc-Val-Cit-PABC-PNPCC(C)[C@H](NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc2ccc(COC(=O)Oc3ccc(cc3)[N+](=O)[O-])cc2
159857-79-1Val-cit-PAB-OHCC(C)[C@H](N)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc1ccc(CO)cc1
159858-22-7Fmoc-Val-Cit-PABCC(C)[C@H](NC(=O)OCC1c2ccccc2c3ccccc13)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc4ccc(CO)cc4
863971-53-3Fmoc-Val-Cit-PAB-PNPCC(C)[C@H](NC(=O)OCC1c2ccccc2c3ccccc13)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc4ccc(COC(=O)Oc5ccc(cc5)[N+](=O)[O-])cc4
2149584-03-0Phe-Lys(Fmoc)-PABN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OCC2c3ccccc3c4ccccc24)C(=O)Nc5ccc(CO)cc5
1116085-99-4Phe-Lys(Trt)-PABN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(c2ccccc2)(c3ccccc3)c4ccccc4)C(=O)Nc5ccc(CO)cc5
1160844-44-9Boc-Phe-(Alloc)Lys-PAB-PNPCC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OCC=C)C(=O)Nc2ccc(COC(=O)Oc3ccc(cc3)[N+](=O)[O-])cc2
159857-90-6Cbz-Phe-(Alloc)Lys-PAB-PNP[O-][N+](=O)c1ccc(OC(=O)OCc2ccc(NC(=O)[C@H](CCCCNC(=O)OCC=C)NC(=O)[C@H](Cc3ccccc3)NC(=O)OCc4ccccc4)cc2)cc1
253863-34-2Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNPC[C@@H](NC(=O)OCC=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OCC=C)C(=O)Nc2ccc(COC(=O)Oc3ccc(cc3)[N+](=O)[O-])cc2
1116086-09-9Fmoc-Phe-Lys(Trt)-PAB-PNP[O-][N+](=O)c1ccc(OC(=O)OCc2ccc(NC(=O)[C@H](CCCCNC(c3ccccc3)(c4ccccc4)c5ccccc5)NC(=O)[C@H](Cc6ccccc6)NC(=O)OCC7c8ccccc8c9ccccc79)cc2)cc1

Fmoc-Gly3-Val-Cit-PAB-OHCC(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)OCC1c2ccccc2c3ccccc13)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc4ccc(CO)cc4

Fmoc-Gly3-Val-Cit-PAB-PNPCC(C)[C@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)OCC1c2ccccc2c3ccccc13)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc4ccc(COC(=O)Oc5ccc(cc5)[N+](=O)[O-])cc4

Mc-Val-Cit-PABC-DiamineCNCCN(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)C=CC2=O)C(C)C)cc1

Mc-PEG2-Val-Cit-PABCC(C)[C@H](NC(=O)CCOCCOCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc2ccc(CO)cc2

DBCO-Val-Cit-PABCC(C)[C@H](NC(=O)CCC(=O)N1Cc2ccccc2C#Cc3ccccc13)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc4ccc(CO)cc4
Glycosidase-Cleavage

β-Glucuronic-PABCOC(=O)[C@H]1O[C@@H](Oc2ccc(CO)cc2NC(=O)CCNC(=O)CCCCCN3C(=O)C=CC3=O)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H]1OC(=O)C

β-Glucuronic-PAB-PNPCOC(=O)[C@H]1O[C@@H](Oc2ccc(COC(=O)Oc3ccc(cc3)[N+](=O)[O-])cc2NC(=O)CCNC(=O)CCCCCN4C(=O)C=CC4=O)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H]1OC(=O)C

β-Galactose-PAB-PNPCC(=O)OC[C@H]1OC(Oc2ccc(COC(=O)Oc3ccc(cc3)[N+](=O)[O-])cc2[N+](=O)[O-])[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@H]1OC(=O)C
Other Linkage
142356-33-06-(Boc-amino)hexyl bromideCC(C)(C)OC(=O)NCCCCCCBr
622405-78-1m-PEG4-NHS esterCOCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O
1025796-31-9(S)-di-tert-butyl   2-(3-((S)-6-amino-1-tert-butoxy-1-oxohexan-2-yl)ureido)pentanedioateCC(C)(C)OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCN)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C
1026987-94-9(S)-5-tert-Butoxy-4-(3-((s)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic   AcidCC(C)(C)OC(=O)CC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C
1127247-34-0m-PEG2-NHS esterCOCCOCCC(=O)ON1C(=O)CCC1=O
Linker Payload

MC-GGFG-PAB-MMAECC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c2ccccc2)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc3ccc(NC(=O)CNC(=O)[C@H](Cc4ccccc4)NC(=O)CNC(=O)CNC(=O)CCCCCN5C(=O)C=CC5=O)cc3)C(C)C
646502-53-6MC-VC-PAB-MMAECC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c2ccccc2)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc3ccc(NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@@H](NC(=O)CCCCCN4C(=O)C=CC4=O)C(C)C)cc3)C(C)C
1401963-17-4VC-MMADCC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc2ccccc2)c3nccs3)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc4ccc(NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@@H](NC(=O)CCCCCN5C(=O)C=CC5=O)C(C)C)cc4)C(C)C
1342820-51-2MC-VAL-ALA-PBDCOc1ccc(cc1)C2=CN3[C@@H](C2)C=Nc4cc(OCCCOc5cc6N=C[C@@H]7CC(=CN7C(=O)c6cc5OC)c8ccc(NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)CCCCCN9C(=O)C=CC9=O)C(C)C)cc8)c(OC)cc4C3=O

SG3249COc1cc2C(=O)N3C=C(C)C[C@H]3C=Nc2cc1OCCCCCOc4cc5N([C@H](O)[C@@H]6CC(=CN6C(=O)c5cc4OC)C)C(=O)OCc7ccc(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCN8C(=O)C=CC8=O)C(C)C)cc7
1599440-13-7MC-GGFG-DXDCC(C)[C@H](NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc2ccc(C[N+](C)(C)CCOc3ccc4[nH]c(cc4c3)C(=O)N5C[C@@H](CCl)c6c5cc(O)c7ccccc67)cc2
2055896-98-3MC-VC-PAB-DuocarmycinCC(C)[C@H](NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc2ccc(C[N+](C)(C)CCOc3ccc4[nH]c(cc4c3)C(=O)N5C[C@@H](CCl)c6c5cc(O)c7ccccc67)cc2
1345681-58-4VC-SECO-DUBACC(C)[C@H](NC(=O)OCCOCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(=O)N)C(=O)Nc2ccc(COC(=O)N(C)CCN(CCOCCO)C(=O)Oc3cc4N(C[C@@H](CCl)c4c5c(C)cccc35)C(=O)c6cn7cc(NC(=O)c8ccc(O)cc8)ccc7n6)cc2

CL2A-SN38CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(O)cc15)[C@](CC)(OC(=O)OCc6ccc(NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCn7cc(CNC(=O)C8CCC(CN9C(=O)C=CC9=O)CC8)nn7)cc6)C(=O)OC4